Corticosteroids

LACC1 gene mutation in three sisters with polyarthritis without systemic features
Ankita Singh, Deepti Suri, Pandiarajan Vignesh, Gummadi Anjani, Prince Jacob, Katta M Girisha

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216263; DOI: 10.1136/annrheumdis-2019-216263
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease
Rachel S Simpson, Stephanie Ka Ching Lau, Jason Kihyuk Lee

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216368; DOI: 10.1136/annrheumdis-2019-216368
Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial
Alexis Mathian, Micheline Pha, Julien Haroche, Fleur Cohen-Aubart, Miguel Hié, Marc Pineton de Chambrun, Thi Huong Du Boutin, Makoto Miyara, Guy Gorochov, Hans Yssel, Patrick Cherin, Hervé Devilliers, Zahir Amoura

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216303; DOI: 10.1136/annrheumdis-2019-216303
Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking
Beth I Wallace, David M Wallace, Akbar K Waljee, Daniel J Clauw

Annals of the Rheumatic Diseases Dec 2019, 78 (12) 1733-1734; DOI: 10.1136/annrheumdis-2019-216009
Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: a French multicentre retrospective study
Thomas Bettuzzi, Alban Deroux, Marie Jachiet, Meryem-Maud Farhat, julien wipff, Marc Fabre, Laurence Bouillet, Nora Kramkimel, Selim Aractingi, Nicolas Dupin, Benjamin Terrier

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1446-1448; DOI: 10.1136/annrheumdis-2019-215605
Response to: ‘Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis’ by Liebling et al
Yoshikazu Nakaoka

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e117; DOI: 10.1136/annrheumdis-2018-214239
What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica?
Jean Jacques Dubost, Bruno Pereira, Angelique Fan, Martin Soubrier

Annals of the Rheumatic Diseases Aug 2019, annrheumdis-2019-216050; DOI: 10.1136/annrheumdis-2019-216050
Steroid sparing effect: an essential element in assessing therapeutic efficacy in SLE: response to ‘Time to change the primary outcome of lupus trials’ by Houssiau
Shereen Oon, Molla Huq, Mandana Nikpour

Annals of the Rheumatic Diseases Aug 2019, annrheumdis-2019-216113; DOI: 10.1136/annrheumdis-2019-216113
Response to: ‘Checkpoint inhibitors and arthritis: seeking balance between victories and defeats’ by Moura and Moura
Thierry Schaeverbeke, Marie Kostine

Annals of the Rheumatic Diseases Sep 2019, 78 (9) e92; DOI: 10.1136/annrheumdis-2018-213906
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al
Christoph T Berger, Thomas Daikeler

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215729; DOI: 10.1136/annrheumdis-2019-215729

Main menu

Corticosteroids

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Corticosteroids

Pages